902 filings
Page 3 of 46
8-K
md5n62vx
19 Jul 23
Departure of Directors or Certain Officers
4:30pm
3
k5v u664g9
19 Jul 23
Armata Pharmaceuticals / Deborah Birx ownership change
9:56am
SC 13D/A
1w835fecrrqgxwjui3n
11 Jul 23
Armata Pharmaceuticals / Innoviva ownership change
8:27am
8-K
kh2sd iu7au5
11 Jul 23
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics
8:15am
8-K
qmucq5j9q
27 Jun 23
Results of Operations and Financial Condition
4:30pm
8-K
vfh7gj0
11 May 23
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update
9:04pm
3
vyaucs
8 May 23
Armata Pharmaceuticals / Julianne Averill ownership change
2:14pm
8-K
udq3kfc9pdrmgfgf
5 May 23
Departure of Directors or Certain Officers
4:38pm
EFFECT
mitohvumu32k1rzmplz
7 Apr 23
Notice of effectiveness
12:15am
424B3
jqqsb7nb7pm5y ectwv
6 Apr 23
Prospectus supplement
4:08pm
CORRESP
q18upj
5 Apr 23
Correspondence with SEC
12:00am
8-K
2yrtue2at jvt2f7ol
16 Mar 23
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update
4:10pm
8-K
u3pl 5qy1nn2c
6 Mar 23
Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis
6:10am
UPLOAD
ti5ws2nrmsl9j1keh
17 Feb 23
Letter from SEC
12:00am
3
lcpk6vfw4mkk3
7 Feb 23
Armata Pharmaceuticals / Erin Butler ownership change
4:00pm